Logo

Marksans Pharma Share Price

Marksans Pharma (INR)260.5-14.4   (-5.3%)

Exchange ScripsBSE524404NSEMARKSANSISININE750C01026

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Marksans Pharma Performance

Market performance
Open price274
High274
Volumes1799554
Prev Close260.5
Low259.5
Closing date2025-01-10
Historical performance
1 Year High358.70
3 Year High358.70
5 Year High358.70
1 Year Low130.00
3 Year Low38.60
5 Year Low9.85

Marksans Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
11811
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
37.63
Dividend Yield
Dividend Yield
0.23 %

Marksans Pharma Investment Returns

1 Year
59.5%
3 Years
322.9%
5 Years
1335.3%
10 Years
283.7%

Marksans Pharma Technicals

IndicatorsValueSignal
5-DMA278.71Bearish
10-DMA287.9Bearish
20-DMA297.11Bearish
50-DMA308.24Bearish
100-DMA290.69Bearish
200-DMA231.18Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters22222
Foreign Investors---------------
Domestic Investors22222
Public Investors248843235498254697237375207935
Government---------------

Marksans Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income50459341967
Operating Profit5090398630073463
Interest112918480
Depreciation743519448362
Profit Before Tax4235337724753022
Consolidated Net Profit3137266318462359
Adjusted EPS7656

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital453453409409
Total Reserves2019716998106828456
Minority Interest209199207189
Total Non-Current Liabilities2052843571237
Total Liabilities26810219041660112280
Capital Work in Progress5472756
Total Assets26810219041660112280

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities230423749931786
Cash Flow from Investing Activities-1408-2592-844-448
Cash Flow from Financing Activitie-6871978795-153
Net Cash Inflow / Outflow20817609441185
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 37.63.
  • 3Y Stock Price CAGR of the stock is 61.3.
  • The stock has a beta of 1.0.
  • In the last financial year, the company had an EBITDA of ₹5090 Million.
  • The company generated revenue of ₹21774 Million in the previous financial year.

Marksans Pharma

260.5-14.4   (-5.3%)

Investment Amount: ₹ 16075
Current Value: ₹ 26050
Performance: 62.1%
P/L: ₹ 9975
Top Gainers
SymbolChange%
NURECA380.7(18%)
CUBEXTUB96.84(16%)
MAZDA1969.9(14%)
ATLASCYCLE112.81(10%)
DNAMEDIA6.99(10%)
Top Losers
SymbolChange%
GTPL130.53(-11%)
GRWRHITECH4286.15(-10%)
AWL291.1(-10%)
SPANDANA405.8(-10%)
JAICORPLTD173(-10%)
DISHTV8.86(-10%)
HARRMALAYA284.45(-9%)
KAMDHENU46.4(-9%)
Similar stocks

Zota Health Care

52.3

994.45

December 12 - January 12

Medico Remedies

28.3

63.14

December 12 - January 12

Brooks Laboratories

26.2

182.06

December 12 - January 12

Bajaj Healthcare

18.8

536.65

December 12 - January 12

Nectar Lifesciences

14.3

38.25

December 12 - January 12

SMS Lifesciences

13.8

1301.8

December 12 - January 12

Blue Jet Healthcare

13.5

571.5

December 12 - January 12

Aarti Pharmalabs

10.5

669.5

December 12 - January 12

Announcing Stock of the Month!

Stock of the Month
Stock of the Month